Mary Kral to Male
This is a "connection" page, showing publications Mary Kral has written about Male.
Connection Strength
0.132
-
Effectiveness and Side Effect Profile of Stimulant Medication for the Treatment of Attention-Deficit/Hyperactivity Disorder in Youth with Epilepsy. J Child Adolesc Psychopharmacol. 2017 Oct; 27(8):735-740.
Score: 0.031
-
Identification of ADHD in youth with epilepsy. J Pediatr Rehabil Med. 2016 09 02; 9(3):223-9.
Score: 0.030
-
Radiographic predictors of neurocognitive functioning in pediatric Sickle Cell disease. J Child Neurol. 2006 Jan; 21(1):37-44.
Score: 0.014
-
Transcranial Doppler ultrasonography and executive dysfunction in children with sickle cell disease. J Pediatr Psychol. 2004 Apr-May; 29(3):185-95.
Score: 0.013
-
Transcranial Doppler ultrasonography and neurocognitive functioning in children with sickle cell disease. Pediatrics. 2003 Aug; 112(2):324-31.
Score: 0.012
-
Formal neurocognitive function and anti-N-methyl-D-aspartate receptor antibodies in paediatric lupus. Lupus Sci Med. 2021 03; 8(1).
Score: 0.010
-
Young Children with Attention-Deficit/Hyperactivity Disorder and/or Disruptive Behavior Disorders Are More Frequently Prescribed Alpha Agonists Than Stimulants. J Child Adolesc Psychopharmacol. 2020 03; 30(2):81-86.
Score: 0.009
-
Not All Generic Concerta Is Created Equal: Comparison of OROS Versus Non-OROS for the Treatment of ADHD. Clin Pediatr (Phila). 2016 Nov; 55(13):1197-1201.
Score: 0.007
-
Ameliorating attention problems in children with sickle cell disease: a pilot study of methylphenidate. J Dev Behav Pediatr. 2012 Apr; 33(3):244-51.
Score: 0.005